Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Prognostic impact of chromosomal abnormalities and copy number alterations in B-cell precursor ALL treated on UKALL14

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 19.12.19
Views: 217
Rating:

Prof Anthony Moorman - Newcastle University, Newcastle, UK

Prof Anthony Moorman speaks to ecancer at the 2019 ASH meeting in Orlando about a study looking at the prognostic impact of chromosomal abnormalities and copy number alterations in B-cell precursor ALL treated on UKALL14.

He reports a new subgroup was identified for patients with a new genetic abnormality known as the JAK-STAT abnormality and they were found to have very poor outcomes.

Prof Moorman also reports that they looked at patients with secondary copy number alterations which was not seen to predict outcomes in adult ALL.

Related videos

follow us

Donate to ecancer


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation